Your browser doesn't support javascript.
loading
Peripheral tissues reprogram CD8+ T cells for pathogenicity during graft-versus-host disease.
Santos E Sousa, Pedro; Ciré, Séverine; Conlan, Thomas; Jardine, Laura; Tkacz, Claire; Ferrer, Ivana R; Lomas, Cara; Ward, Sophie; West, Heather; Dertschnig, Simone; Blobner, Sven; Means, Terry K; Henderson, Stephen; Kaplan, Daniel H; Collin, Matthew; Plagnol, Vincent; Bennett, Clare L; Chakraverty, Ronjon.
Afiliação
  • Santos E Sousa P; Haematology, UCL Cancer Institute and Institute of Immunity & Transplantation, London, United Kingdom (UK).
  • Ciré S; Haematology, UCL Cancer Institute and Institute of Immunity & Transplantation, London, United Kingdom (UK).
  • Conlan T; Haematology, UCL Cancer Institute and Institute of Immunity & Transplantation, London, United Kingdom (UK).
  • Jardine L; Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK.
  • Tkacz C; UCL Genetics Institute, London, UK.
  • Ferrer IR; Haematology, UCL Cancer Institute and Institute of Immunity & Transplantation, London, United Kingdom (UK).
  • Lomas C; Haematology, UCL Cancer Institute and Institute of Immunity & Transplantation, London, United Kingdom (UK).
  • Ward S; Haematology, UCL Cancer Institute and Institute of Immunity & Transplantation, London, United Kingdom (UK).
  • West H; Haematology, UCL Cancer Institute and Institute of Immunity & Transplantation, London, United Kingdom (UK).
  • Dertschnig S; Haematology, UCL Cancer Institute and Institute of Immunity & Transplantation, London, United Kingdom (UK).
  • Blobner S; Haematology, UCL Cancer Institute and Institute of Immunity & Transplantation, London, United Kingdom (UK).
  • Means TK; Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital, Charlestown, Massachusetts, USA.
  • Henderson S; Bill Lyons Informatics Centre, UCL Cancer Institute, London, UK.
  • Kaplan DH; Department of Immunology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
  • Collin M; Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK.
  • Plagnol V; UCL Genetics Institute, London, UK.
  • Bennett CL; Haematology, UCL Cancer Institute and Institute of Immunity & Transplantation, London, United Kingdom (UK).
  • Chakraverty R; Haematology, UCL Cancer Institute and Institute of Immunity & Transplantation, London, United Kingdom (UK).
JCI Insight ; 3(5)2018 03 08.
Article em En | MEDLINE | ID: mdl-29515032
ABSTRACT
Graft-versus-host disease (GVHD) is a life-threatening complication of allogeneic stem cell transplantation induced by the influx of donor-derived effector T cells (TE) into peripheral tissues. Current treatment strategies rely on targeting systemic T cells; however, the precise location and nature of instructions that program TE to become pathogenic and trigger injury are unknown. We therefore used weighted gene coexpression network analysis to construct an unbiased spatial map of TE differentiation during the evolution of GVHD and identified wide variation in effector programs in mice and humans according to location. Idiosyncrasy of effector programming in affected organs did not result from variation in T cell receptor repertoire or the selection of optimally activated TE. Instead, TE were reprogrammed by tissue-autonomous mechanisms in target organs for site-specific proinflammatory functions that were highly divergent from those primed in lymph nodes. In the skin, we combined the correlation-based network with a module-based differential expression analysis and showed that Langerhans cells provided in situ instructions for a Notch-dependent T cell gene cluster critical for triggering local injury. Thus, the principal determinant of TE pathogenicity in GVHD is the final destination, highlighting the need for target organ-specific approaches to block immunopathology while avoiding global immune suppression.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pele / Linfócitos T Citotóxicos / Células de Langerhans / Reprogramação Celular / Doença Enxerto-Hospedeiro Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pele / Linfócitos T Citotóxicos / Células de Langerhans / Reprogramação Celular / Doença Enxerto-Hospedeiro Idioma: En Ano de publicação: 2018 Tipo de documento: Article